This meeting is supported by:

OVERVIEW

The Society for Medicines Research is pleased to announce the latest in the series of SMR Awards Meetings. The 2025 SMR Award for Drug Discovery has been presented to lenacapavir, developed by Gilead Sciences, in recognition of its outstanding innovation and transformative potential in improving adherence, reducing treatment burden, and advancing public health goals in HIV management and prevention.

The meeting will also feature presentations highlighting recent clinical candidates in a range of therapeutic areas including oncology and infectious diseases.

This meeting is sure to offer great opportunities for scientific discussion and networking.

Sponsorship:
Sponsorship opportunities are available for this event.
Click here to download the Sponsorship Opportunities flyer and booking form.

Fees: